Skip to main content

LSV ASSET MANAGEMENT

Position in EBS — Emergent BioSolutions Inc.

CIK 1050470 CHICAGO, IL

Position in EBS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$14,211,231
+$6,768,621 QoQ
Shares Held
1,695,851
+89.1% QoQ
Ownership
3.31%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#6
of 193 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 65% Shared 0% None 35%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

LSV ASSET MANAGEMENT holds $404,370,158 across 20 Drug Manufacturers - Specialty & Generic names. EBS ranks #5 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 EBS
Emergent BioSolutions Inc.
This page
1,695,851 $14,211,231

All Filings in EBS

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,211,231 1,695,851
2026-03-31 $7,442,610 896,700
2025-12-31 $11,136,360 901,000
2025-09-30 $7,624,890 864,500
2025-06-30 $5,203,470 815,591
2025-03-31 $4,039,588 831,191
2024-12-31 $206,496 21,600
2023-06-30 $299,145 40,700
2023-03-31 $738,419 71,276
2022-12-31 $1,248,033 105,676
2022-06-30 $3,280,183 105,676
2022-03-31 $4,339,056 105,676
2021-12-31 $3,976,461 91,476
2021-09-30 $1,517,121 30,300
2021-06-30 $1,908,597 30,300
2021-03-31 $2,815,173 30,300
2020-12-31 $2,956,800 33,000
2020-09-30 $2,676,247 25,900
2020-06-30 $2,048,172 25,900
2020-03-31 $1,764,730 30,500